These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18491963)

  • 41. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Cheng MP; Paquette K; Lands LC; Ovetchkine P; Théoret Y; Quach C
    Pediatr Pulmonol; 2010 Jul; 45(7):661-6. PubMed ID: 20575095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Voriconazole-associated myositis.
    Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
    J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voriconazole-induced retinoid-like photosensitivity in children.
    Rubenstein M; Levy ML; Metry D
    Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of voriconazole in critically ill patients with invasive mycoses].
    Alvarez Lerma F
    Rev Iberoam Micol; 2007 Sep; 24(3):209-12. PubMed ID: 17874857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of voriconazole hepatotoxicity in a lung transplant patient.
    Belaiche S; Roustit M; Bedouch P; Quetant S; Saint-Raymond C; Pison C
    Transpl Infect Dis; 2011 Jun; 13(3):309-11. PubMed ID: 21176020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
    Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
    Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Voriconazole-induced photosensitivity.
    Malani AN; Aronoff DM
    Clin Med Res; 2008 Sep; 6(2):83-5. PubMed ID: 18801950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D; Buadi FK; McClune B
    Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature.
    Masamoto Y; Nannya Y; Kurokawa M
    J Chemother; 2011 Feb; 23(1):17-23. PubMed ID: 21482489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.
    Camuset J; Nunes H; Dombret MC; Bergeron A; Henno P; Philippe B; Dauriat G; Mangiapan G; Rabbat A; Cadranel J
    Chest; 2007 May; 131(5):1435-41. PubMed ID: 17400661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
    Papy E; Carde A; Ribaud P; Faure P; Touratier S
    Presse Med; 2006 Feb; 35(2 Pt 1):251-2. PubMed ID: 16493359
    [No Abstract]   [Full Text] [Related]  

  • 54. What is the "therapeutic range" for voriconazole?
    Lewis RE
    Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252
    [No Abstract]   [Full Text] [Related]  

  • 55. Voriconazole in the treatment of invasive fungal infections.
    Keady S; Thacker M
    Intensive Crit Care Nurs; 2005 Dec; 21(6):370-3. PubMed ID: 15985371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
    Lyoen M; Rostain F; Grimault A; Minello A; Sgro C
    Fundam Clin Pharmacol; 2013 Oct; 27(5):570-1. PubMed ID: 22834415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
    McCarthy KL; Playford EG; Looke DF; Whitby M
    Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The safety of voriconazole.
    Potoski BA; Brown J
    Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experience with voriconazole in invasive aspergillosis].
    Thiel E; Schwartz S
    Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M; Flowers SA; Rogers PD
    Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.